Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxycodone + lorazepam is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Oxycodone is an opioid analgesic used for the management of moderate to severe pain. It acts primarily as an agonist at the mu-opioid receptor, altering the perception and response to pain in the central nervous system. Lorazepam is a benzodiazepine indicated for anxiety disorders, status epilepticus, and as a preanesthetic agent; it works by enhancing the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors in the brain, producing anxiolytic, sedative, anticonvulsant, and muscle relaxant effects. The concurrent use of these agents significantly increases risks due to additive central nervous system depression—most notably profound sedation and respiratory depression—which can be fatal[1][2][4][5]. This combination does not have a unique brand or product name but refers specifically to co-administration or co-prescription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxycodone + lorazepam.